CD4 and head and neck squamous cell carcinoma: Boucek et al. analyzed the blood samples from 112 patients with head and neck squamous cell carcinoma lymphocyte subpopulations (CD3+; CD3−CD16+CD56+; CD4+; CD8+; CD19+; CD4+CD45RA+).